Masako Harada

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Bioengineering (Basel, Switzerland)

Cancers

Science and technology of advanced materials

Michigan State University

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Michigan State University Jul 01 2017

United States

Assistant Professor :: Biomedical Engineering

Education History

Karolinska Institutet

Sweden

PHD :: Oncology and Pathology

King's College London

United Kingdom

BSC :: Molecular Genetics

Publications

Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada, Kaveh Baghaei
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada, Kaveh Baghaei
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 37 (3) (2023)
Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada, Kaveh Baghaei
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada, Kaveh Baghaei
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 37 (3) (2023)
Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada, Kaveh Baghaei
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 37 (3) (2023)
Amir Hossein Mohammadi, Zeinab Ghazvinian, Fatemeh Bagheri, Masako Harada, Kaveh Baghaei
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Yuki Kawai-Harada, Hanine El Itawi, Hiroaki Komuro, Masako Harada
Evaluation of EV Storage Buffer for Efficient Preservation of Engineered Extracellular Vesicles. International journal of molecular sciences 24 (16) (2023)
Hiroaki Komuro, Shakhlo Aminova, Katherine Lauro, Daniel Woldring, Masako Harada
Design and Evaluation of Engineered Extracellular Vesicle (EV)-Based Targeting for EGFR-Overexpressing Tumor Cells Using Monobody Display. Bioengineering (Basel, Switzerland) 9 (2) (2022)
Hiroaki Komuro, Shakhlo Aminova, Katherine Lauro, Masako Harada
Advances of engineered extracellular vesicles-based therapeutics strategy. Science and technology of advanced materials 23 (1) (2022)
Ping Wang, Taeho Kim, Masako Harada, Christopher Contag, Xuefei Huang, Bryan Ronain Smith
Nano-immunoimaging. Nanoscale horizons 5 (4) (2021)
Alexis Forterre, Hiroaki Komuro, Shakhlo Aminova, Masako Harada
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies. Cancers 12 (7) (2020)

Masako Harada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masako Harada